Healthcare -
Biotechnology - NASDAQ - US
$ 2.89
-1.03 %
$ 1.75 B
Market Cap
-9.03
P/E
GERN - TOTAL CURRENT LIABILITIES
Total Current Liabilities GERN - Geron Corporation
108 M
LAST VALUE
54.08%
2 YEAR CAGR
70.27%
5 YEAR CAGR
30.43%
10 YEAR CAGR